Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART). (Q39200059)

9 September 2017

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART). (English)

1 reference

9 September 2017

anti-retroviral agent

0 references

7

José Eduardo Levi

1 reference

9 September 2017

Daisy Maria Machado

1

1 reference

9 September 2017

Silvana Cláudia Fernandes

2

1 reference

9 September 2017

Regina Célia de Menezes Succi

3

1 reference

9 September 2017

Wilton Santos Freire

4

1 reference

9 September 2017

Cláudio Sérgio Pannuti

5

1 reference

9 September 2017

Aída Barbosa Gouveia

6

1 reference

9 September 2017

Ricardo Sobie Diaz

8

1 reference

9 September 2017

1 January 2005

1 reference

Revista do Instituto de Medicina Tropical de São Paulo

9 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

9 September 2017

47

1 reference

9 September 2017

1

1 reference

9 September 2017

1-5

1 reference

Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy

9 September 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Chemokines and receptors in HIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Sequencing antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Persistence of earlier HIV-1 drug resistance mutations at new treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000100001

10.1590/S0036-46652005000100001

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference